nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluoxymesterone—Coma hepatic—Docetaxel—melanoma	0.0167	0.177	CcSEcCtD
Fluoxymesterone—Clotting—Temozolomide—melanoma	0.00882	0.0937	CcSEcCtD
Fluoxymesterone—Coagulopathy—Dactinomycin—melanoma	0.00447	0.0475	CcSEcCtD
Fluoxymesterone—Coagulopathy—Temozolomide—melanoma	0.00405	0.043	CcSEcCtD
Fluoxymesterone—Menstruation irregular—Docetaxel—melanoma	0.00378	0.0402	CcSEcCtD
Fluoxymesterone—Testosterone Propionate—CYP17A1—melanoma	0.00368	0.19	CrCbGaD
Fluoxymesterone—Amenorrhoea—Temozolomide—melanoma	0.00358	0.0381	CcSEcCtD
Fluoxymesterone—Gynaecomastia—Carmustine—melanoma	0.00292	0.031	CcSEcCtD
Fluoxymesterone—Alopecia—Vemurafenib—melanoma	0.00273	0.0291	CcSEcCtD
Fluoxymesterone—Amenorrhoea—Docetaxel—melanoma	0.00238	0.0253	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Vemurafenib—melanoma	0.0022	0.0234	CcSEcCtD
Fluoxymesterone—Haemoglobin—Bleomycin—melanoma	0.00188	0.02	CcSEcCtD
Fluoxymesterone—Haemorrhage—Bleomycin—melanoma	0.00188	0.0199	CcSEcCtD
Fluoxymesterone—Progesterone—CYP17A1—melanoma	0.00169	0.087	CrCbGaD
Fluoxymesterone—Alopecia—Bleomycin—melanoma	0.00166	0.0176	CcSEcCtD
Fluoxymesterone—Haemoglobin—Carmustine—melanoma	0.00165	0.0175	CcSEcCtD
Fluoxymesterone—Haemorrhage—Carmustine—melanoma	0.00164	0.0174	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Vemurafenib—melanoma	0.00162	0.0172	CcSEcCtD
Fluoxymesterone—Haemoglobin—Temozolomide—melanoma	0.00159	0.0169	CcSEcCtD
Fluoxymesterone—Haemorrhage—Temozolomide—melanoma	0.00158	0.0168	CcSEcCtD
Fluoxymesterone—Dexamethasone—CYP17A1—melanoma	0.00155	0.0796	CrCbGaD
Fluoxymesterone—Alopecia—Dactinomycin—melanoma	0.00155	0.0164	CcSEcCtD
Fluoxymesterone—Alopecia—Carmustine—melanoma	0.00145	0.0154	CcSEcCtD
Fluoxymesterone—Alopecia—Temozolomide—melanoma	0.0014	0.0149	CcSEcCtD
Fluoxymesterone—Headache—Vemurafenib—melanoma	0.00138	0.0146	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Bleomycin—melanoma	0.00133	0.0142	CcSEcCtD
Fluoxymesterone—Nausea—Vemurafenib—melanoma	0.00131	0.0139	CcSEcCtD
Fluoxymesterone—Dexamethasone—NOS2—melanoma	0.00126	0.0649	CrCbGaD
Fluoxymesterone—Anxiety—Carmustine—melanoma	0.00121	0.0128	CcSEcCtD
Fluoxymesterone—Paraesthesia—Bleomycin—melanoma	0.0012	0.0127	CcSEcCtD
Fluoxymesterone—Progesterone—CYP1B1—melanoma	0.00117	0.0603	CrCbGaD
Fluoxymesterone—Anxiety—Temozolomide—melanoma	0.00117	0.0124	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Temozolomide—melanoma	0.00112	0.0119	CcSEcCtD
Fluoxymesterone—Testosterone—CYP1B1—melanoma	0.00111	0.057	CrCbGaD
Fluoxymesterone—Dexamethasone—CYP1B1—melanoma	0.00107	0.0552	CrCbGaD
Fluoxymesterone—Haemoglobin—Docetaxel—melanoma	0.00106	0.0112	CcSEcCtD
Fluoxymesterone—Haemorrhage—Docetaxel—melanoma	0.00105	0.0112	CcSEcCtD
Fluoxymesterone—Paraesthesia—Carmustine—melanoma	0.00104	0.0111	CcSEcCtD
Fluoxymesterone—Paraesthesia—Temozolomide—melanoma	0.00101	0.0107	CcSEcCtD
Fluoxymesterone—Megestrol acetate—ABCB1—melanoma	0.001	0.0514	CrCbGaD
Fluoxymesterone—Hypersensitivity—Bleomycin—melanoma	0.000981	0.0104	CcSEcCtD
Fluoxymesterone—Alopecia—Docetaxel—melanoma	0.000929	0.00988	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Dactinomycin—melanoma	0.000915	0.00973	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Carmustine—melanoma	0.000857	0.0091	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Temozolomide—melanoma	0.000828	0.0088	CcSEcCtD
Fluoxymesterone—Nausea—Bleomycin—melanoma	0.000791	0.00841	CcSEcCtD
Fluoxymesterone—Triamcinolone—PTGS2—melanoma	0.00076	0.0391	CrCbGaD
Fluoxymesterone—Anaphylactic shock—Docetaxel—melanoma	0.000747	0.00794	CcSEcCtD
Fluoxymesterone—Nausea—Dactinomycin—melanoma	0.000738	0.00784	CcSEcCtD
Fluoxymesterone—Headache—Carmustine—melanoma	0.000728	0.00774	CcSEcCtD
Fluoxymesterone—Headache—Temozolomide—melanoma	0.000704	0.00748	CcSEcCtD
Fluoxymesterone—Nausea—Carmustine—melanoma	0.000691	0.00734	CcSEcCtD
Fluoxymesterone—Paraesthesia—Docetaxel—melanoma	0.000671	0.00713	CcSEcCtD
Fluoxymesterone—Nausea—Temozolomide—melanoma	0.000667	0.00709	CcSEcCtD
Fluoxymesterone—Betamethasone—PTGS2—melanoma	0.000622	0.032	CrCbGaD
Fluoxymesterone—Spironolactone—ABCB1—melanoma	0.000622	0.032	CrCbGaD
Fluoxymesterone—Norethindrone—ALB—melanoma	0.000605	0.0311	CrCbGaD
Fluoxymesterone—Norethindrone—ABCB1—melanoma	0.000577	0.0297	CrCbGaD
Fluoxymesterone—Methyltestosterone—ALB—melanoma	0.000574	0.0296	CrCbGaD
Fluoxymesterone—Hypersensitivity—Docetaxel—melanoma	0.000551	0.00585	CcSEcCtD
Fluoxymesterone—Prednisolone—ABCB1—melanoma	0.00054	0.0278	CrCbGaD
Fluoxymesterone—Betamethasone—ABCB1—melanoma	0.000529	0.0272	CrCbGaD
Fluoxymesterone—Headache—Docetaxel—melanoma	0.000468	0.00497	CcSEcCtD
Fluoxymesterone—Nausea—Docetaxel—melanoma	0.000444	0.00472	CcSEcCtD
Fluoxymesterone—Hydrocortisone—ABCB1—melanoma	0.000413	0.0212	CrCbGaD
Fluoxymesterone—Dexamethasone—PTGS2—melanoma	0.000362	0.0186	CrCbGaD
Fluoxymesterone—Progesterone—ABCB1—melanoma	0.000336	0.0173	CrCbGaD
Fluoxymesterone—Testosterone—ALB—melanoma	0.000333	0.0171	CrCbGaD
Fluoxymesterone—Testosterone—ABCB1—melanoma	0.000318	0.0164	CrCbGaD
Fluoxymesterone—Dexamethasone—ABCB1—melanoma	0.000308	0.0158	CrCbGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—PTEN—melanoma	0.000253	0.000285	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—CDKN1A—melanoma	0.000252	0.000284	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—KRAS—melanoma	0.000252	0.000284	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—NFKB1—melanoma	0.000251	0.000284	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—PTEN—melanoma	0.000251	0.000283	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—STAT3—melanoma	0.000251	0.000283	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	0.000249	0.000281	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—melanoma	0.000249	0.000281	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—TNF—melanoma	0.000247	0.000279	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—BRAF—melanoma	0.000246	0.000278	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	0.000245	0.000277	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	0.000245	0.000277	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—NFKB1—melanoma	0.000241	0.000272	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	0.00024	0.000271	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—STAT3—melanoma	0.00024	0.00027	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IGF1—melanoma	0.00024	0.00027	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—melanoma	0.00024	0.00027	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—NRAS—melanoma	0.000239	0.00027	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—RPS3—melanoma	0.000239	0.000269	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—NPPA—melanoma	0.000239	0.000269	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—melanoma	0.000236	0.000266	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—RPS3—melanoma	0.000235	0.000265	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—SKI—melanoma	0.000235	0.000265	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—SNRPE—melanoma	0.000235	0.000265	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—melanoma	0.000234	0.000264	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	0.000232	0.000262	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MAP2K1—melanoma	0.000232	0.000261	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—SNRPE—melanoma	0.000231	0.000261	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—SKI—melanoma	0.000231	0.000261	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PIK3CD—melanoma	0.00023	0.00026	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—MAPK3—melanoma	0.000229	0.000258	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—VEGFA—melanoma	0.000228	0.000257	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	0.000227	0.000256	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—MYC—melanoma	0.000226	0.000255	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—NRAS—melanoma	0.000224	0.000253	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—TP53—melanoma	0.000224	0.000252	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—CDKN2B—melanoma	0.000223	0.000251	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	0.000223	0.000251	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	0.000221	0.000249	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	0.000221	0.000249	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—FGF2—melanoma	0.00022	0.000249	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—CDKN2B—melanoma	0.00022	0.000248	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—VEGFA—melanoma	0.000219	0.000247	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—MAPK1—melanoma	0.000218	0.000246	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—EGFR—melanoma	0.000218	0.000246	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—VDR—melanoma	0.000217	0.000245	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—TNF—melanoma	0.000217	0.000245	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	0.000217	0.000245	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	0.000215	0.000242	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—MAPK3—melanoma	0.000215	0.000242	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—VDR—melanoma	0.000214	0.000242	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TNF—melanoma	0.00021	0.000237	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—MYC—melanoma	0.00021	0.000237	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	0.00021	0.000237	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	0.000209	0.000236	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	0.000209	0.000235	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—NOTCH1—melanoma	0.000208	0.000235	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	0.000208	0.000235	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CXCL1—melanoma	0.000208	0.000235	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PLCB4—melanoma	0.000208	0.000235	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MDM2—melanoma	0.000206	0.000233	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—KRAS—melanoma	0.000206	0.000232	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—MAPK1—melanoma	0.000205	0.000232	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—EGFR—melanoma	0.000205	0.000232	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—MAPK1—melanoma	0.000204	0.00023	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—EGFR—melanoma	0.000204	0.00023	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—ERBB2—melanoma	0.000203	0.000229	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PIK3CB—melanoma	0.000201	0.000226	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—IL6—melanoma	0.0002	0.000225	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—PPARG—melanoma	0.000197	0.000222	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TRRAP—melanoma	0.000196	0.000221	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CUL3—melanoma	0.000196	0.000221	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—KRAS—melanoma	0.000194	0.000219	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—KRAS—melanoma	0.000193	0.000218	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CXCL8—melanoma	0.000193	0.000217	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	0.000192	0.000216	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—AKR1B10—melanoma	0.00019	0.000215	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—PIK3CA—melanoma	0.000189	0.000213	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	0.000189	0.000213	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—AKT1—melanoma	0.000189	0.000213	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CDKN1B—melanoma	0.000188	0.000212	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—TNF—melanoma	0.000188	0.000212	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TP53—melanoma	0.000185	0.000209	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CASP3—melanoma	0.000184	0.000208	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IL2—melanoma	0.000184	0.000208	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—NPPA—melanoma	0.000184	0.000207	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—NPPA—melanoma	0.000181	0.000204	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CCND1—melanoma	0.00018	0.000203	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	0.000179	0.000202	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CTNNB1—melanoma	0.000178	0.000201	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—PIK3CA—melanoma	0.000177	0.0002	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—F2RL1—melanoma	0.000177	0.000199	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—IL6—melanoma	0.000175	0.000198	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—HRAS—melanoma	0.000175	0.000197	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—HDAC2—melanoma	0.000174	0.000197	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MMP9—melanoma	0.000174	0.000197	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	0.000174	0.000196	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CDKN1A—melanoma	0.000174	0.000196	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PTEN—melanoma	0.000173	0.000196	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—NFKB1—melanoma	0.000172	0.000195	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—TP53—melanoma	0.000172	0.000194	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	0.00017	0.000192	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	0.00017	0.000192	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—IL6—melanoma	0.000167	0.000189	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GRM3—melanoma	0.000166	0.000188	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—HRAS—melanoma	0.000164	0.000185	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	0.000162	0.000183	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	0.000161	0.000181	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—NOTCH1—melanoma	0.000161	0.000181	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—NOTCH1—melanoma	0.000158	0.000178	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—KISS1—melanoma	0.000158	0.000178	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—IL6—melanoma	0.000157	0.000177	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	0.000157	0.000177	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—VEGFA—melanoma	0.000157	0.000177	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—STAT3—melanoma	0.000155	0.000175	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—NRAS—melanoma	0.000155	0.000174	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—AKT1—melanoma	0.000154	0.000174	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SKI—melanoma	0.000153	0.000172	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CXCR1—melanoma	0.000153	0.000172	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—PPARG—melanoma	0.000152	0.000171	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—IL6—melanoma	0.000151	0.000171	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MC1R—melanoma	0.00015	0.00017	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—PPARG—melanoma	0.000149	0.000168	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MAPK3—melanoma	0.000148	0.000167	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	0.000148	0.000167	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—AKT1—melanoma	0.000146	0.000164	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—AKT1—melanoma	0.000145	0.000163	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CCR7—melanoma	0.000144	0.000163	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GRM1—melanoma	0.000144	0.000163	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MYC—melanoma	0.000144	0.000162	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	0.000143	0.000161	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MAPK1—melanoma	0.000141	0.000159	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—EGFR—melanoma	0.000141	0.000159	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SUFU—melanoma	0.00014	0.000158	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—CDKN2B—melanoma	0.000139	0.000157	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—VDR—melanoma	0.000136	0.000153	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—HDAC2—melanoma	0.000134	0.000152	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—KRAS—melanoma	0.000133	0.00015	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—HDAC2—melanoma	0.000132	0.000149	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—RHOB—melanoma	0.000131	0.000148	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—BCL2L11—melanoma	0.000131	0.000148	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HDAC6—melanoma	0.000126	0.000142	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—PRKCA—melanoma	0.000125	0.000141	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—ERCC2—melanoma	0.000124	0.00014	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PIK3CA—melanoma	0.000122	0.000138	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	0.000121	0.000136	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CXCR2—melanoma	0.000119	0.000135	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TP53—melanoma	0.000118	0.000133	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—RAC2—melanoma	0.000118	0.000133	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—VEGFC—melanoma	0.000116	0.000131	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—WNT5A—melanoma	0.000116	0.000131	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—HRAS—melanoma	0.000113	0.000128	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—MYC—melanoma	0.000112	0.000127	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IL6—melanoma	0.000108	0.000122	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—CDKN2B—melanoma	0.000107	0.000121	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—CDKN2B—melanoma	0.000106	0.000119	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—VDR—melanoma	0.000105	0.000118	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—VDR—melanoma	0.000103	0.000116	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—F2R—melanoma	0.000102	0.000115	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—NOTCH1—melanoma	0.0001	0.000113	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—AKT1—melanoma	9.99e-05	0.000113	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—EDNRB—melanoma	9.84e-05	0.000111	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—PRKCA—melanoma	9.65e-05	0.000109	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—ERCC2—melanoma	9.57e-05	0.000108	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PTK2B—melanoma	9.55e-05	0.000108	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—PRKCA—melanoma	9.51e-05	0.000107	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—PPARG—melanoma	9.47e-05	0.000107	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—ERCC2—melanoma	9.43e-05	0.000106	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GAB2—melanoma	9.29e-05	0.000105	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GNA11—melanoma	9.29e-05	0.000105	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—FLT1—melanoma	9.25e-05	0.000104	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HDAC2—melanoma	8.73e-05	9.85e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CXCR4—melanoma	8.73e-05	9.85e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—FOXO4—melanoma	8.73e-05	9.85e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—MYC—melanoma	8.64e-05	9.75e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GNAQ—melanoma	8.64e-05	9.74e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—MYC—melanoma	8.51e-05	9.6e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SYK—melanoma	8.12e-05	9.16e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ITGAV—melanoma	7.97e-05	8.99e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—AKT3—melanoma	7.97e-05	8.99e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NGFR—melanoma	7.97e-05	8.99e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—NOTCH1—melanoma	7.73e-05	8.72e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—NOTCH1—melanoma	7.61e-05	8.59e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SOCS1—melanoma	7.38e-05	8.33e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—S100B—melanoma	7.36e-05	8.3e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—PPARG—melanoma	7.3e-05	8.23e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—PPARG—melanoma	7.19e-05	8.11e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ERBB4—melanoma	7.04e-05	7.94e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CDKN2B—melanoma	6.98e-05	7.87e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CD86—melanoma	6.75e-05	7.61e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—EDN1—melanoma	6.7e-05	7.55e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CSF2—melanoma	6.55e-05	7.38e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—FGF1—melanoma	6.55e-05	7.38e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—E2F1—melanoma	6.41e-05	7.23e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PDGFRA—melanoma	6.34e-05	7.15e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PRKCA—melanoma	6.28e-05	7.08e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ITGB3—melanoma	6.28e-05	7.08e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SPP1—melanoma	6.15e-05	6.94e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MAP2K2—melanoma	6.13e-05	6.92e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TERT—melanoma	5.83e-05	6.58e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—RAC1—melanoma	5.82e-05	6.56e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HIF1A—melanoma	5.58e-05	6.29e-05	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—MAPK3—melanoma	5.55e-05	6.26e-05	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—MYC—melanoma	5.4e-05	6.09e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—KDR—melanoma	5.34e-05	6.02e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—FN1—melanoma	5.14e-05	5.79e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NOTCH1—melanoma	5.03e-05	5.67e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CD80—melanoma	4.92e-05	5.55e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—KIT—melanoma	4.92e-05	5.54e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PIK3CG—melanoma	4.92e-05	5.54e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—APC—melanoma	4.92e-05	5.54e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—EGF—melanoma	4.86e-05	5.48e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—BRAF—melanoma	4.62e-05	5.21e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IGF1—melanoma	4.5e-05	5.08e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MAP2K1—melanoma	4.35e-05	4.91e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PIK3CD—melanoma	4.32e-05	4.87e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—MAPK3—melanoma	4.28e-05	4.82e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—MAPK3—melanoma	4.21e-05	4.75e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—MYC—melanoma	4.16e-05	4.69e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—FGF2—melanoma	4.14e-05	4.67e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—MYC—melanoma	4.1e-05	4.62e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MDM2—melanoma	3.87e-05	4.37e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ERBB2—melanoma	3.82e-05	4.31e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PIK3CB—melanoma	3.77e-05	4.25e-05	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—AKT1—melanoma	3.74e-05	4.22e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CXCL8—melanoma	3.62e-05	4.08e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CDKN1B—melanoma	3.53e-05	3.99e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CASP3—melanoma	3.46e-05	3.91e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IL2—melanoma	3.46e-05	3.9e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CCND1—melanoma	3.37e-05	3.8e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CTNNB1—melanoma	3.34e-05	3.77e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MMP9—melanoma	3.27e-05	3.69e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CDKN1A—melanoma	3.26e-05	3.68e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PTEN—melanoma	3.25e-05	3.67e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NFKB1—melanoma	3.24e-05	3.65e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—VEGFA—melanoma	2.94e-05	3.32e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—STAT3—melanoma	2.91e-05	3.28e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NRAS—melanoma	2.9e-05	3.28e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—AKT1—melanoma	2.88e-05	3.25e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—AKT1—melanoma	2.84e-05	3.2e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MAPK3—melanoma	2.78e-05	3.14e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MYC—melanoma	2.7e-05	3.05e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MAPK1—melanoma	2.65e-05	2.98e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—EGFR—melanoma	2.65e-05	2.98e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—KRAS—melanoma	2.5e-05	2.82e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PIK3CA—melanoma	2.3e-05	2.59e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TP53—melanoma	2.22e-05	2.51e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HRAS—melanoma	2.12e-05	2.4e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IL6—melanoma	2.03e-05	2.29e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—AKT1—melanoma	1.88e-05	2.12e-05	CbGpPWpGaD
